
AZOLES AND DUTASTERIDE
Potent CYP3A4 inhibitors (itraconazole, ketoconazole) may cause a clinically signifi- cant rise in dutasteride levels.
The manufacturers suggest reducing the dosing frequency if increased dutasteride
adverse effects occur.
The manufacturers suggest reducing the dosing frequency if increased dutasteride
adverse effects occur.